Skip to main content
Menu
Go to Dashboard
Help
Français
Login
2.6.6.3 :: 2.6.6.3 :: 2026/04/28 12:02
Dashboard
Services
Request access
Search
Profiles
Documents
Disciplined list
Cease trade orders
View reporting issuers list
Home
BriaCell Therapeutics Corp. (000024134)
Company details
Regulatory actions
On this page
Documents
Profile details
Company identification
Reporting issuer details
Formation details
Financial year end
Size and industry classification
Securities
Associated entities
Previous issuers
Documents
Search and download documents for this profile
Profile details
Profile number
000024134
Status
Public
Full legal company name in English
BriaCell Therapeutics Corp.
Full legal company name in French
BriaCell Therapeutics Corp.
Effective from date
26 Jul 2006
Show previous name history
Previous name in English
ANSELL CAPITAL CORP.
Previous name in French
ANSELL CAPITAL CORP.
Effective up to date
01 Jan 1500
This company is an Investment Fund Manager
No
This company is an Underwriter
No
Head office address
3rd Floor, Bellevue Centre, 235-15th St., West Vancouver, British Columbia, V7T 2X1, Canada
Mailing address
3rd Floor, Bellevue Centre, 235-15th St., 3rd Floor, Bellevue Centre, West Vancouver, British Columbia, V7T 2X1, Canada
Telephone number
+1 (888) 485-6340 (Main)
Fax number
+1 (424) 245-3719
Email address
glevin@briacell.com
Website
www.briacell.com
Company identification
Legal entity identifier (LEI)
529900NQNTTXYE874283
Reporting issuer details
Reporting issuer
Yes
Over-The-Counter (OTC) issuer
No
Exchangeable Security or Credit Support issuer
Not applicable
Capital Pool Company (CPC)
No
Eligible for short form prospectus
Yes
Principal jurisdiction
British Columbia
Reporting jurisdiction(s)
Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Ontario, Prince Edward Island, Québec, Saskatchewan, Yukon
Formation details
Date of formation
26 Jul 2006
Manner of formation
Corporation
Jurisdiction where formed
Canada, British Columbia
Chief Executive Officer (CEO) - full legal name
WILLIAMS, William V.
Chief Financial Officer (CFO) - full legal name
LEVIN, Gadi
Financial year end
Type of financial year end
Fixed year end
Financial year end
July 31
Size and industry classification
NAICS
541710 - Research and development in the physical, engineering and life sciences
Size of issuer (assets)
$25 million to under $100 million
Securities
Listed on an exchange or other market place
Yes
Select exchange(s) or other market place(s) Add at least one Stock Exchange or other Market Place
Exchange or market place
Toronto Stock Exchange (TSX) - BCT
Nasdaq - ---
CUSIP
10778Y
ISIN
CA10778Y3023
Associated entities
Transfer agent or registrar
Computershare Investor Services Inc.
3rd Floor, 510 Burrard St., Vancouver, British Columbia, V6C 3B9, Canada
T: +1 (604) 661-0296
F: +1 (604) 661-9401
Francesca.Power@computershare.com
Auditor
MNP LLP, Chartered Accountants / MNP LLP, Chartered Accountants
Address
701 Evans Av. 8th Floor, Toronto, Ontario, M9C 1A3, Canada
T: +1 (416) 626-6000
F: +1 (416) 626-8650
isabella.lee@mnp.ca
Previous issuers
Previous issuer(s)
No
Unsaved changes will be lost. Are you sure you wish to exit?
No
Yes
Unsaved changes will be lost. Are you sure you want to cancel?
No
Yes
???label.checkSubmitMsg???
Cancel
???label.submitOnly???
Hide page help
About SEDAR+
Contact Us
Glossary
Copyright © 2023 British Columbia Securities Commission, Alberta Securities Commission, Ontario Securities Commission, Autorité des marchés financiers. All rights reserved.
2.6.6.3 :: 2.6.6.3 :: 2026/04/28 12:02
Print